Emerging respiratory infectious diseases pose a substantial risk for humans due to their extremely high potential to spread from person-to-person. Influenza viruses are highly contagious respiratory viruses that lead to pandemics, annual epidemics, and frequent spillovers in humans. Influenza viruses have been circulating among numerous birds and mammals. Spillovers of influenza viruses from other species to humans are frequently reported. Currently, influenza viruses are co-circulating with SARS-CoV-2 worldwide. It is ever more challenging to identify influenza viruses with the greatest risk of pandemics. Developing efficient therapeutic and prophylactic strategies against the influenza viruses are urgently required. This will be possible to win the “war” with influenza by deepening the understanding of influenza virus transmission and evolution within and between hosts (i.e. humans, swine, avian), exploring virus and host associated factors impacting virus pathogenesis and immune response, and developing novel therapeutic approaches as well as vaccine strategies that overcome the limitations of existing approaches.
This research topic will aim to highlight the most advanced research studies on influenza virus transmission, pathogenesis, virus-host interactions, therapeutic approaches, and vaccination strategies. We welcome the submission of Original Research Articles, Brief Research Reports, Comprehensive Reviews, and Mini-Reviews that address the above issues. The submission can cover, but not necessarily limited to the following sub-topics as:
1. Influenza virus transmission within/between birds, mammals (dogs, swine, horse, etc) and humans
2. Influenza virus ecology, evolution and co-infection/interaction with bacteria and/or other viruses
3. Influenza virus pathogenicity and virulence determinants
4. Influenza virus-host interaction, cell tropism and immune response
5. Development of therapeutic strategies including antivirals, antibodies, and treatments
6. Development of vaccines including vaccination strategies, vaccine strain selection, characterization, and optimization
7. Impact of host associated factors on influenza virus vaccines and therapeutics
8. Novel methods for influenza virus characterization, therapeutic and vaccine strategies
Emerging respiratory infectious diseases pose a substantial risk for humans due to their extremely high potential to spread from person-to-person. Influenza viruses are highly contagious respiratory viruses that lead to pandemics, annual epidemics, and frequent spillovers in humans. Influenza viruses have been circulating among numerous birds and mammals. Spillovers of influenza viruses from other species to humans are frequently reported. Currently, influenza viruses are co-circulating with SARS-CoV-2 worldwide. It is ever more challenging to identify influenza viruses with the greatest risk of pandemics. Developing efficient therapeutic and prophylactic strategies against the influenza viruses are urgently required. This will be possible to win the “war” with influenza by deepening the understanding of influenza virus transmission and evolution within and between hosts (i.e. humans, swine, avian), exploring virus and host associated factors impacting virus pathogenesis and immune response, and developing novel therapeutic approaches as well as vaccine strategies that overcome the limitations of existing approaches.
This research topic will aim to highlight the most advanced research studies on influenza virus transmission, pathogenesis, virus-host interactions, therapeutic approaches, and vaccination strategies. We welcome the submission of Original Research Articles, Brief Research Reports, Comprehensive Reviews, and Mini-Reviews that address the above issues. The submission can cover, but not necessarily limited to the following sub-topics as:
1. Influenza virus transmission within/between birds, mammals (dogs, swine, horse, etc) and humans
2. Influenza virus ecology, evolution and co-infection/interaction with bacteria and/or other viruses
3. Influenza virus pathogenicity and virulence determinants
4. Influenza virus-host interaction, cell tropism and immune response
5. Development of therapeutic strategies including antivirals, antibodies, and treatments
6. Development of vaccines including vaccination strategies, vaccine strain selection, characterization, and optimization
7. Impact of host associated factors on influenza virus vaccines and therapeutics
8. Novel methods for influenza virus characterization, therapeutic and vaccine strategies
